ESG

Edesa Biotech pushes its pipeline forward with a new vitiligo trial and promising ARDS data, but rising R&D costs highlight the high stakes of innovation.

The biotech firm is set to launch its first commercial products, using an innovative strategy to tackle long-neglected markets in women's healthcare.

As the healthcare industry bleeds talent, PruittHealth's fifth consecutive 'Great Place to Work' award reveals its culture-first strategy for retention and growth.

A novel device that treats hypertension from outside the artery shows early promise, challenging market leaders and offering new hope for millions.

Trace Adkins to debut a new anthem and a massive fireworks show at Mount Vernon will launch the nation's Semiquincentennial birthday party on July 3rd.

Ottawa unveils a bold national strategy to double its power grid, linking economic growth to clean electricity, but faces questions on cost and climate.

Soaring costs and long waits at home are driving thousands of Europeans to Albania for dental implants, where clinics offer top-tier care for less.

Deltec Homes is making its famously storm-proof round houses more personal, adding custom-inspired features to its faster, more affordable prefab lineup.

A new retrospective reveals Linda McCartney as a pioneering photographer, activist, and entrepreneur whose influence extends far beyond her famous name.

Saudi Arabia's sovereign wealth fund is now a key sponsor for the 2026 World Cup, a deal that brings FIFA financial security but fuels global debate.

Senti Biosciences advances its AML cell therapy to a registrational trial after FDA meeting and a key discovery that quadruples patient response rates.

Minset's mCoder AI achieved state-of-the-art results on a demanding industry benchmark, signaling a new era of accurate, auditable autonomous coding.

With a major new financing round, BlueWind Medical is set to expand access to its innovative Revi® System for urgency urinary incontinence.

An ambitious challenge aims to turn Amazon biodiversity into sustainable businesses, betting that entrepreneurship is the key to the rainforest's survival.

As burnout and addiction surge among executives, doctors, and first responders, a new program offers a confidential, career-conscious path to recovery.

Many top professionals are diagnosed with ADHD, but a new analysis claims the real cause is childhood conditioning, not neurology. Is the cure a misstep?

The biopharma posts record Q1 revenue and profit, driven by its flagship DefenCath and a key acquisition, while a promising pipeline signals future growth.

OrganOx names Terumo's Naoya Iwata as new CEO, signaling a major push to expand its life-saving organ transplant technology across the globe.

A new film documents Robert Wickens' incredible return to racing, tackling the treacherous Nürburgring 24 Hours after a paralyzing crash.

Early human trial data for a new drug, UDP-003, suggests it can safely remove toxic cholesterol, a key step toward reversing arterial plaque buildup.